Sound waves zap kidney tumors in new Non-Invasive trial

NCT ID NCT05820087

Ongoing Disease control Sponsor: HistoSonics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device that uses focused sound waves (histotripsy) to break apart kidney tumors without making any cuts. About 67 adults with a single small kidney mass (3 cm or less) that hasn't spread will be treated. The goal is to see if the tumors are completely gone after one session and if the procedure is safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign neoplasm kidney cancer kidney neoplasm neoplasm renal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY CANCER RENAL CANCER TUMOR TUMOR, BENIGN TUMOR, SOLID

Contacts and locations

Locations

AdventHealth Celebration

Celebration, Florida, 34747, United States
Icahn School of Medicine Mount Sinai

New York, New York, 10029, United States
Johns Hopkins University

Baltimore, Maryland, 21287, United States
Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
NYU Langone Health

New York, New York, 10016, United States
Northwell Health

Lake Success, New York, 11042, United States
Providence Mission Hosptial

Mission Viejo, California, 92691, United States
Swedish Medical Center

Seattle, Washington, 98122, United States
The Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43212, United States
UT Southwestern Medical Center

Dallas, Texas, 75390, United States
University of California, Los Angeles (UCLA)

Los Angeles, California, 90095, United States
University of Rochester Medical Center

Rochester, New York, 14642, United States
University of Southern California

Los Angeles, California, 90089, United States
University of Wisconsin School of Medicine and Public Health

Madison, Wisconsin, 53705, United States
Yale School of Medicine

New Haven, Connecticut, 06510, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.